Cargando…
The impacts of COVID-19 on glaucoma patient outcomes as assessed by POEM
Autores principales: | Pujari, Rathin, Chan, Geoffrey, Tapply, Ian, Bourne, Rupert R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7871516/ https://www.ncbi.nlm.nih.gov/pubmed/33564139 http://dx.doi.org/10.1038/s41433-021-01425-0 |
Ejemplares similares
-
Lessons learned from the development and implementation of a patient-reported outcome and experience measure (POEM) in an Australian glaucoma practice
por: Fraenkel, Alison, et al.
Publicado: (2019) -
An update on long-acting therapies in chronic sight-threatening eye diseases of the posterior segment: AMD, DMO, RVO, uveitis and glaucoma
por: Ghanchi, Faruque, et al.
Publicado: (2022) -
Treatment and outcomes of POEMS syndrome: changes in the past 20 years
por: Yu, Yan-ying, et al.
Publicado: (2021) -
Improving Adherence to Topical Medication in Patients with Glaucoma
por: Tapply, Ian, et al.
Publicado: (2021) -
Intravitreal Bevacizumab for the Treatment of Optic Disc Edema in a Patient with POEMS Syndrome
por: Kim, Do Wook, et al.
Publicado: (2015)